Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-033744

Options or other derivatives

  • CEO and President acquired 356,741 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kendall Keith J · CEO and President

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-07-24 Grant or award : show line 1 in the form Stock Option (Right to Purchase) +240,165 240,165 D
2018-07-24 Grant or award : show line 2 in the form Restricted Stock Unit +116,576 116,576 D
Loading xslF345X03/form4.xml…